Sanders Jessica N, Simonsen Sara E, Porucznik Christina A, Hammoud Ahmad O, Smith Ken R, Stanford Joseph B
Department of Obstetrics and Gynecology, University of Utah, S30 N 1900 E, Rm 2B200, Salt Lake City, UT, 84132, USA.
Department of Family and Preventive Medicine, University of Utah School of Medicine, 375 Chipeta Way Ste A., Salt Lake City, UT, 84108, USA.
Reprod Health. 2022 Mar 29;19(1):83. doi: 10.1186/s12978-022-01363-4.
In vitro fertilization (IVF) births contribute to a considerable proportion of preterm birth (PTB) each year. However, there is no formal surveillance of adverse perinatal outcomes for less invasive fertility treatments. The study objective was to describe associations between fertility treatment (in vitro fertilization, intrauterine insemination, usually with ovulation drugs (IUI), or ovulation drugs alone) and preterm birth, compared to no treatment in subfertile women.
The Fertility Experiences Study (FES) is a retrospective cohort study conducted at the University of Utah between April 2010 and September 2012. Women with a history of primary subfertility self-reported treatment data via survey and interviews. Participant data were linked to birth certificates and fetal death records to asses for perinatal outcomes, particularly preterm birth.
A total 487 birth certificates and 3 fetal death records were linked as first births for study participants who completed questionnaires. Among linked births, 19% had a PTB. After adjustment for maternal age, paternal age, maternal education, annual income, religious affiliation, female or male fertility diagnosis, and duration of subfertility, the odds ratios and 95% confidence intervals (CI) for PTB were 2.17 (CI 0.99, 4.75) for births conceived using ovulation drugs, 3.17 (CI 1.4, 7.19) for neonates conceived using IUI and 4.24 (CI 2.05, 8.77) for neonates conceived by IVF, compared to women with subfertility who used no treatment during the month of conception. A reported diagnosis of female factor infertility increased the adjusted odds of having a PTB 2.99 (CI 1.5, 5.97). Duration of pregnancy attempt was not independently associated with PTB. In restricting analyses to singleton gestation, odds ratios were not significant for any type of treatment.
IVF, IUI, and ovulation drugs were all associated with a higher incidence of preterm birth and low birth weight, predominantly related to multiple gestation births.
体外受精(IVF)分娩每年在早产(PTB)中占相当大的比例。然而,对于侵入性较小的生育治疗,尚无对围产期不良结局的正式监测。本研究的目的是描述与未接受治疗的不育女性相比,生育治疗(体外受精、宫腔内人工授精,通常联合促排卵药物(IUI)或仅使用促排卵药物)与早产之间的关联。
生育经历研究(FES)是一项于2010年4月至2012年9月在犹他大学进行的回顾性队列研究。有原发性不育病史的女性通过调查和访谈自行报告治疗数据。将参与者数据与出生证明和胎儿死亡记录相链接,以评估围产期结局,尤其是早产情况。
共有487份出生证明和3份胎儿死亡记录与完成问卷的研究参与者的头胎相链接。在有链接的分娩中,19%为早产。在对产妇年龄、父亲年龄、产妇教育程度、年收入、宗教信仰、女性或男性生育诊断以及不育持续时间进行调整后,与受孕当月未接受治疗的不育女性相比,使用促排卵药物受孕的分娩早产的比值比及95%置信区间(CI)为2.17(CI 0.99,4.75),使用IUI受孕的新生儿为3.17(CI 1.4,7.19),通过IVF受孕的新生儿为4.24(CI 2.05,8.77)。报告的女性因素不孕症诊断使早产的调整后比值比增加至2.99(CI 1.5,5.97)。尝试怀孕的持续时间与早产无独立关联。在将分析限制于单胎妊娠时,任何类型治疗的比值比均无统计学意义。
IVF、IUI和促排卵药物均与早产和低出生体重的较高发生率相关,主要与多胎妊娠分娩有关。